Skip to content

Clinical trials

Phase 2 Panic Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Panic Disorder Phase: Phase 2 Country / region: United States Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20072
20081
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
New York State Psychiatric Institute2
AbbVie1
Alexza Pharmaceuticals, Inc.1
Beth Israel Medical Center1
Boston University Charles River Campus1
HB BioTech, LLC1
National Institute on Drug Abuse (NIDA)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Panic Disorder8
Anxiety Disorders3
Mental Disorders2
Alcoholism1
Generalized Anxiety Disorder1
Major Depressive Disorder1
Neurologic Manifestations1
Phobia, Social1
Rare Diseases1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.